国联医药消费混合A(015032)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-4,580,444.98 |
31,354,635.27 |
24,346,185.89 |
-12,519,625.39 |
| 利息合计 |
7,991.46 |
28,105.51 |
18,348.93 |
47,479.38 |
| 其中:存款利息收入 |
7,991.46 |
28,105.51 |
18,348.93 |
47,479.38 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-5,163,062.75 |
30,450,793.93 |
14,522,213.22 |
-9,657,635.58 |
| 其中:股票投资收益 |
-5,338,530.86 |
29,758,573.29 |
13,912,493.51 |
-10,130,055.82 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
3.75 |
- |
- |
-440.97 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
175,464.36 |
692,220.64 |
609,719.71 |
472,861.21 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
233,521.29 |
511,054.06 |
9,593,458.33 |
-3,437,040.10 |
| 其他收入 |
341,105.02 |
364,681.77 |
212,165.41 |
527,570.91 |
| 费用 |
436,530.66 |
1,319,666.24 |
820,230.88 |
1,328,611.51 |
| 管理人报酬 |
287,483.46 |
874,910.42 |
527,850.69 |
854,651.55 |
| 基金托管费 |
47,913.89 |
145,818.48 |
87,975.14 |
142,441.91 |
| 销售服务费 |
63,956.07 |
218,377.42 |
149,269.16 |
221,495.42 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
37,177.24 |
80,559.92 |
55,135.89 |
110,022.63 |
| 利润总额 |
-5,016,975.64 |
30,034,969.03 |
23,525,955.01 |
-13,848,236.90 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年